← Back to Clinical Trials
Recruiting NCT07440836

NCT07440836 Effects of Corrective Versus Plank Exercises on Diastasis Recti

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07440836
Status Recruiting
Phase
Sponsor Riphah International University
Condition Diastasis Recti
Study Type INTERVENTIONAL
Enrollment 56 participants
Start Date 2025-01-01
Primary Completion 2026-07-01

Eligibility & Interventions

Sex Female only
Min Age 25 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
corrective exercisesPlank Exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 56 participants in total. It began in 2025-01-01 with a primary completion date of 2026-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will be randomized clinical trial and will be conducted in Services Hospital and poly clinics. The total duration of treatment will be 12 weeks. Non-probability convenience sampling technique will be used and 56 participants will be recruited in study after randomization. The participants are randomly assigned to one of two groups: Group A performs corrective exercises focused on deep core engagement, while Group B performs plank exercises aimed at overall abdominal activation. Each group follows their respective regimen three times per week for 12 weeks. Baseline EMS and pelvic floor exercises are conducted for all participants to ensure core stability before the interventions begin. Outcome measures, including manual muscle testing (MMT) for strength, and the Numerical Pain Rating Scale (NPRS) for pain, are recorded both before and after the 12-week intervention. After data collection data will be analyzed by using SPSS version 25.

Eligibility Criteria

Inclusion Criteria: * If IRD is greater than 4cm and above * Postpartum females * Three months to three years postpartum with presence of diastasis rectus abdominis * Vaginal delivery * Multiparous * Pain greater than 6 on NPRS Exclusion Criteria: * Subjects with any heart condition, respiratory condition * Any pelvic or abdominal surgery * Any neurological disease eg preeclampsia, epilepsy * Trauma to bowel or bladder * Prior history of physical therapy treatment for pelvic floor issues * Postpartum depression

Contact & Investigator

Central Contact

imran amjad, PhD

✉ imran.amjad@riphah.edu.pk

📞 03324390125

Principal Investigator

adeela arif, t-DPT

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07440836 clinical trial?

This trial is open to female participants only, aged 25 Years or older, up to 40 Years, studying Diastasis Recti. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07440836 currently recruiting?

Yes, NCT07440836 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT07440836 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT07440836 clinical trial?

NCT07440836 is sponsored by Riphah International University. The principal investigator is adeela arif, t-DPT at Riphah International University. The trial plans to enroll 56 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology